Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05732272 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Improving Smoking Abstinence Outcomes in the African American Community Through Extended Treatment

Study acronym: (KISV)
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Oct 31, 2026 to Jan 31, 2027v6
  2. Primary completion date: Sep 30, 2026 to Oct 31, 2026 Completion date: Mar 31, 2027 to Apr 30, 2027v5 Show 1 more changeShow less
    • Completion date: Mar 31, 2027 to Apr 30, 2027
  3. Primary completion date: Jan 15, 2026 to Sep 30, 2026 Completion date: Jul 30, 2026 to Mar 31, 2027v4 Show 1 more changeShow less
    • Completion date: Jul 30, 2026 to Mar 31, 2027
  4. Primary completion date: Nov 30, 2025 to Jan 15, 2026 Completion date: Mar 30, 2026 to Jul 30, 2026v3 Show 1 more changeShow less
    • Completion date: Mar 30, 2026 to Jul 30, 2026
  5. Trial status: Not Yet Recruiting to Recruiting Primary completion date: Aug 30, 2025 to Nov 30, 2025 · Completion date: Dec 30, 2025 to Mar 30, 2026 · Start date changed from estimate of Feb 27, 2023 to Feb 28, 2023 · 2 morev2 Show 5 more changesShow less
    • Primary completion date: Aug 30, 2025 to Nov 30, 2025
    • Completion date: Dec 30, 2025 to Mar 30, 2026
    • Start date changed from estimate of Feb 27, 2023 to Feb 28, 2023
    • Eligibility criteria shortened, about 10 words
    • Site details revised

    See this version in full on ClinicalTrials.gov ↗

  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will evaluate the efficacy of extended bupropion(6 months) versus standard bupropion treatment (7 weeks) among African American daily smokers.
Trial Details
NCT Number NCT05732272
Lead Sponsor University of Kansas Medical Center
Conditions Smoking Cessation
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov